兔急性房颤时心房肌钙通道α1C、β1及钾通道Ikr的表达和药物干预(4)
 |
| 第1页 |
参见附件。
[9] Curran ME，Splawski I，Timothy KW，et al.A molecular basis for cardiac arrhythmia：HERG mutations cause long QT syndrome[J].Cell，1995，80(5)：795-803.
[10] Manios EG，Kanoupakis EM，Chlouverakis GI，et al.Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation：Relation with recurrence[J].Cardiovascular Research，2000，47(2)：244-253.
[11] Yue L，Feng J，Gaspo R，et al.Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation[J].Circ Res，1997，81(4)：512-525.
[12] Li D，Zhang L，Kneller J，et al.Potential ionic mechanism for repolarization differences between canine right and left atrium[J].Circ Res，2001，88 (11)：1168-1175.
[13] Lai LP，Su ML，Lin JL，et al，Changers in the mRNA levels of delayed rectifier potassium channels in human atrial fibrillation[J].Cardiology，1999，92(4)：248-255.
[14] Ellenbogen KA，Stambler BS，Wood MA，et al.Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter：A dose-response study [J].J Am Coll Cardiol，1996，28(1)：130-136.
[15] Stambleer BS，Wood MA，Ellenbogen KA，et al.Efficacy and safety of repeated intravenous doses of ibultlide for rapid conversion of atrial flutter or bibrillation[J].Circulation，1996，94(7)：1613-1621.
[16] 李宁，霍有平，浦介麟，等.通络药物对心肌细胞钠钙离子通道的影响[J].中华医学杂志，2007，87(14)：995-998.
(收稿日期：2013-01-31)
您现在查看是摘要介绍页，详见PDF附件。